Cargando…
Omalizumab: Clinical Use for the Management of Asthma
Omalizumab, a humanized monoclonal antibody that binds circulating IgE antibody, is a treatment option for patients with moderate to severe allergic asthma whose asthma is poorly controlled with inhaled corticosteroids and inhaled long-acting β(2) agonist bronchodilators. This review considers the m...
Autores principales: | Thomson, Neil C., Chaudhuri, Rekha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382304/ https://www.ncbi.nlm.nih.gov/pubmed/22745565 http://dx.doi.org/10.4137/CCRPM.S7793 |
Ejemplares similares
-
Update on optimal use of omalizumab in management of asthma
por: Pelaia, Girolamo, et al.
Publicado: (2011) -
A review of omalizumab for the management of severe asthma
por: Lin, Ching-Hsiung, et al.
Publicado: (2016) -
Identification and management of adults with asthma prone to exacerbations: can we do better?
por: Thomson, Neil C, et al.
Publicado: (2008) -
Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008) -
Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)